An Effectiveness-Implementation Trial of SPIRIT in ESRD
SPIRIT 在 ESRD 中的有效性实施试验
基本信息
- 批准号:10205754
- 负责人:
- 金额:$ 15.6万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-06-01 至 2022-03-31
- 项目状态:已结题
- 来源:
- 关键词:2019-nCoVAcuteAddressAdmission activityAdvance Care PlanningAdvance DirectivesAffectAnxietyAreaBehaviorBelief SystemCOVID-19COVID-19 pandemicCaregiversCaringCessation of lifeCharacteristicsChronic DiseaseCluster randomized trialComplexConflict (Psychology)Control GroupsDataDecision MakingDisastersDisease OutbreaksEducational BackgroundEnd stage renal failureEthnic OriginExhibitsFamilyFrightGenderGoalsHealthHealthcareHospitalizationIncomeIndividualInfectionInterventionLearningLifeLiteratureLongitudinal cohort studyMeasuresMedicalModelingNatural DisastersOutcomePanicPaperParentsPatient RecruitmentsPatientsPerceptionQuestionnairesRaceReadinessReflex actionResearchResourcesRiskSocial ChangeSocioeconomic StatusSpecific qualifier valueStressTimeUncertaintyUpdateWithdrawalaggressive therapybasebehavioral economicsbehavioral/social sciencecare outcomescare preferencecognitive performancecoronavirus diseaseeconomic impacteffectiveness implementation trialend of lifeend of life careend-of-life decision makingevidence baseexperiencefollow-upgroup interventionhigh riskinterestmultiple chronic conditionsnovelpandemic diseasepost interventionpreferencepsychologicrecruitresilienceresponserisk perceptionsexsocialsocial health determinantssociodemographics
项目摘要
ABSTRACT
This R01 supplement submitted in response to NOT-OD-20-097, Research on the 2019 Novel Coronavirus
and the Behavioral and Social Sciences, addresses one of the four focused areas specified in the notice: to
examine “downstream health impacts resulting from social, behavioral, and economic impacts, including
differences in risks and resiliency based on gender, race and ethnicity, socioeconomic status, and other social
determinants of health.” The COVID pandemic has brought fear and uncertainty to all aspects of life and
especially to medical care. Research has shown that after experiencing a natural disaster, people exhibit more
risk averse behaviors, and that belief systems can change: people “update” their perception of background risk
and perceive the world to be a much riskier place. Although studies have shown that values and preferences
for end-of-life care are stable over time especially after individuals made an effort to actively think about their
end-of-life preferences, another body of literature suggests that abrupt and disturbing social changes, such as
disasters, can affect the psychological mechanisms underlying cognitive performance. The effects of a
disaster may bring doubt to clinicians as well as to families regarding how to interpret an advance directive or
end-of-life care preferences that were expressed some time prior to the pandemic. There is very little empirical
data to guide advance care planning (ACP) with our sickest patients in the setting of a disaster and especially
one that is so novel. Therefore, we seek to learn whether in the setting of this novel disaster patients with
serious chronic illness are more or less likely to want aggressive treatment. This supplement research is to
generate new empirical data on the impact of the COVIDE-19 pandemic on patients' end-of-life preferences, to
address whether the stability of preferences is disrupted by the pandemic, and to identify patient
characteristics, including race/ethnicity, associated with pre-/post-pandemic changes. We will leverage the
parent study (R01NR017018), a cluster randomized trial of an evidence-based ACP intervention (SPIRIT), in
which we are currently following 143 dyads (65% Blacks) who successfully completed both the baseline and 2-
week post-intervention follow-up before the outbreak. In this new longitudinal cohort study, we will recruit 100
dyads from the pool of 143 to repeat the study assessment battery 2 more times along with new COVID-19
Stress Scales. The specific aims are to: 1) compare the stability of patients' goals-of-care preferences over
time, from pre-outbreak to during-outbreak, by group (SPIRIT vs control) and estimate effect by race (Blacks
and Whites); 2) assess the stability in the preparedness outcomes (dyad congruence, patient decisional
conflict, and surrogate decision-making confidence) comparing pre-outbreak to during-outbreak by group, and
estimate race effect; and 3) examine the associations of the COVID-19 Stress, sex, race/ethnicity, and other
sociodemographic characteristics (e.g., education level, income) to change in the outcomes and the stability of
patients' goals-of-care preferences after the COVID-19 outbreak.
摘要
本R 01补充文件是针对NOT-OD-20-097《2019年新型冠状病毒研究》提交的
以及行为和社会科学,涉及通知中指定的四个重点领域之一:
研究“社会、行为和经济影响对下游健康的影响,包括
基于性别、种族和民族、社会经济地位和其他社会因素的风险和弹性差异
健康的决定因素”。新型冠状病毒大流行给生活的各个方面带来了恐惧和不确定性,
特别是医疗保健。研究表明,在经历自然灾害后,人们表现出更多的
风险规避行为,以及信念系统可以改变:人们“更新”他们对背景风险的看法
并认为世界是一个更危险的地方。尽管研究表明价值观和偏好
随着时间的推移,特别是在个人努力积极思考他们的生活之后,
另一个文献表明,突然和令人不安的社会变化,如
灾难,可以影响认知表现的心理机制。的效果
灾难可能会给临床医生和家庭带来关于如何解释预先指示的疑问,
在大流行病爆发前一段时间就表达了对临终关怀的偏好。很少有经验的
数据,以指导我们的病情最严重的患者在灾难的设置,特别是
一个如此新奇的故事。因此,我们试图了解,在这种新的灾难设置的病人,
严重的慢性病或多或少需要积极的治疗。这项补充研究是为了
生成关于COVIDE-19大流行对患者临终偏好影响的新经验数据,
解决偏好的稳定性是否被大流行破坏,并确定患者
与大流行前/后变化相关的特征,包括种族/民族。我们将利用
母研究(R 01 NR 017018),一项基于证据的ACP干预(SPIRIT)的随机分组试验,
我们目前正在跟踪143对夫妇(65%的黑人),他们成功地完成了基线和2-
干预后一周的后续行动在爆发之前。在这项新的纵向队列研究中,我们将招募100名
从143个样本池中抽取二对样本,与新的COVID-19一起再重复2次研究评估组合沿着
压力量表。具体目标是:1)比较患者的护理目标偏好的稳定性,
按组(SPIRIT与对照组)列出的从爆发前到爆发期间的时间,以及按人种(黑人)列出的估计效应
和白人); 2)评估准备结果的稳定性(二元一致性,患者决策
冲突和替代决策信心),按组比较爆发前和爆发期间,以及
估计种族效应;以及3)检查COVID-19压力,性别,种族/民族和其他
社会人口特征(例如,教育水平、收入)对结果的变化和
COVID-19爆发后患者的护理目标偏好。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MI-KYUNG SONG其他文献
MI-KYUNG SONG的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MI-KYUNG SONG', 18)}}的其他基金
Center for the Study of Symptom Science, Metabolomics and Multiple Chronic Conditions
症状科学、代谢组学和多种慢性病研究中心
- 批准号:
9763654 - 财政年份:2018
- 资助金额:
$ 15.6万 - 项目类别:
An Effectiveness-Implementation Trial of SPIRIT in ESRD
SPIRIT 在 ESRD 中的有效性实施试验
- 批准号:
10361836 - 财政年份:2017
- 资助金额:
$ 15.6万 - 项目类别:
An Effectiveness-Implementation Trial of SPIRIT in ESRD
SPIRIT 在 ESRD 中的有效性实施试验
- 批准号:
9301866 - 财政年份:2017
- 资助金额:
$ 15.6万 - 项目类别:
An Effectiveness-Implementation Trial of SPIRIT in ESRD
SPIRIT 在 ESRD 中的有效性实施试验
- 批准号:
9890004 - 财政年份:2017
- 资助金额:
$ 15.6万 - 项目类别:
Preparation for End of Life Decision Making in Mild Alzheimer's Disease
轻度阿尔茨海默病临终决策的准备
- 批准号:
9922847 - 财政年份:2017
- 资助金额:
$ 15.6万 - 项目类别:
Preparation for End of Life Decision Making in Mild Alzheimer's Disease
轻度阿尔茨海默病临终决策的准备
- 批准号:
9423416 - 财政年份:2017
- 资助金额:
$ 15.6万 - 项目类别:
Mapping Multidimensional Illness Trajectories of Patients With ESKD
绘制 ESKD 患者的多维疾病轨迹
- 批准号:
8521388 - 财政年份:2011
- 资助金额:
$ 15.6万 - 项目类别:
Mapping Multidimensional Illness Trajectories of Patients With ESKD
绘制 ESKD 患者的多维疾病轨迹
- 批准号:
8257799 - 财政年份:2011
- 资助金额:
$ 15.6万 - 项目类别:
Mapping Multidimensional Illness Trajectories of Patients With ESKD
绘制 ESKD 患者的多维疾病轨迹
- 批准号:
8725529 - 财政年份:2011
- 资助金额:
$ 15.6万 - 项目类别:
Mapping Multidimensional Illness Trajectories of Patients With ESKD
绘制 ESKD 患者的多维疾病轨迹
- 批准号:
8339362 - 财政年份:2011
- 资助金额:
$ 15.6万 - 项目类别:
相似海外基金
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 15.6万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 15.6万 - 项目类别:
Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 15.6万 - 项目类别:
Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 15.6万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 15.6万 - 项目类别:
Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 15.6万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 15.6万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 15.6万 - 项目类别:
Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 15.6万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
- 批准号:
484000 - 财政年份:2023
- 资助金额:
$ 15.6万 - 项目类别:
Operating Grants














{{item.name}}会员




